Author:
Rossom Rebecca C.,Crain A. Lauren,O'Connor Patrick J.,Wright Eric,Haller Irina V.,Hooker Stephanie A.,Sperl-Hillen JoAnn M.,Olson Anthony,Romagnoli Katrina,Solberg Leif,Dehmer Steven P.,Haapala Jacob,Borgert-Spaniol Caitlin,Tusing Lorraine,Muegge Jule,Allen Clayton,Ekstrom Heidi,Huntley Kristen,McCormack Jennifer,Bart Gavin
Funder
National Institute on Drug Abuse Treatment Clinical Trials Network
National Institutes of Health
U.S. Department of Health and Human Services
National Institute on Drug Abuse
Subject
Pharmacology (medical),General Medicine
Reference36 articles.
1. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health,2020
2. National and state Treatment need and capacity for Opioid agonist medication-assisted Treatment;Jones;Am. J. Public Health,2015
3. Substance Abuse and Mental Health Services Administration, Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63 Publication No. PEP21-02-01-002,2021
4. Infectious complications of injection drug Use;Marks;Med. Clin. North Am.,2022
5. Integrated models of Care for Individuals with Opioid Use Disorder: how do we prevent HIV and HCV?;Rich;Curr. HIV/AIDS Rep.,2018
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献